Idiopathic acute transverse myelitis: A clinical study and prognostic markers in 45 cases

Multiple Sclerosis

Volumn 12, Issue 2, 2006, Pages 169-173

  Bruna Escuer, Jordi ^a,c   Martinez Yelamos S ^a   Martinez Yelamos A ^b   Rubio, F ^a   Arbizu, T ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DE VILADECANS   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Acute transverse myelitis; Glucose; Myelitis; Prognostic factors

Indexed keywords

GLUCOSE; METHYLPREDNISOLONE;

ACUTE DISEASE; ADULT; AGE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC DISEASE; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RANKIN SCALE; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; PROGNOSIS;

EID: 33645811740     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135248506ms1260oa     Document Type: Article

References (29)

1. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002; 59: 499-505.
2. Seze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasteurel U, Gauvrit JY et al. Acute myelopathies. Clinical, laboratory and outcome profiles in 79 cases. Brain 2001; 124: 1509-21.
3. Harzheim M, Schlegel U, Urbach H, Klockgether T, Schmidt S. Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 2004; 217: 217-23.
4. Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981; 31: 966-71.
5. Lipton HL, Teasdall RD. Acute transverse myelopathy in adults. A follow up study. Arch Neurol 1973; 28: 252-57.
6. Christensen PB, Wermuth L, Hinge H, Bomers K. Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 1990; 81: 431-35.
7. Misra UK, Kalita J, Kumar S. A clinical, MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci 1996; 138: 150-56.
8. Ropper AH, Poskanzer DC. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 1978; 4: 51-59.
9. Al Deeb SM, Yaqub BA, Bruyn GW, Biary NM. Acute transverse myelitis. A localized form of post-infectious encephalomyelitis. Brain 1997; 120: 1115-22.
10. Martinelli V, Comi G, Rovaris M, Filippi M, Colombo B, Locatelli T et al. Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short-and-long term prognostic factors. J Neurol 1995; 242: 497-503.
11. Irani DN, Kerr DA. 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 2000; 355: 901. (Letter)
12. Seze J, Peoc'h K, Ferriby D, Stojkovic T, Laplanche JL, Vermersch P. 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis. J Neurol 2002; 249: 626-27.
13. Burn JP. Reliability of the modified Rankin scale. Stroke 1992; 23: 438. (Letter)
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
15. Tintoré M, Rovira A, Martínez J, Diaz-Villalosada P, Brieva L, Borras C et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 702-706.
16. O'Riordan JI, Thomson AJ, Kingsley DP, MacManus DG, Kendall BE, Rudge P et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998; 121: 495-503.
17. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thomson AJ, Miller DH. A longitudinal study of abnormalities on MRI disability from multiple sclerosis. N Engl J Med 2002; 346: 158-64.
18. Tintoré M, Rovira A, Rio J, Nos C, Grive E, Tellez N et al. Is optic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 2005; 57: 210-15.
19. Campi A, Filippi M, Comi G, Martinelli V, Baratti C, Rovaris M et al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. AJNR Am J Neuroradiol 1995; 16: 115-23.
20. Krishnan C, Kaplin AI, Calabresi PA, Kerr DA. Clinical characteristics and prognostic factors in 170 patients with idiopathic transverse myelitis. Neurology 2004; 62 (Suppl 5): A231.
21. Kagansky N, Shmuel L, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 2001; 58: 1209-12.
22. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology 2003; 61: 1351-56.
23. Murros K, Fogelholm R, Kettunen S, Vuorela AL, Valve J. Serum cortisol and outcome of ischemic brain infarction. J Neurol Sci 1993; 116: 12-17.
24. Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and paO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999; 30: 160-70.
25. Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A et al. Transverse myelitis in patients with anti-phospholipid antibodies. The importance of early diagnosis and treatment. Clin Rheumatol 2002; 21: 207-10.
26. Loblaw DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol 1998; 16: 1613-24.
27. Filippini G, Brusaferri F, Sibley WA, Citterio A, Ciucci G, Midgard R et al. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database Syst Rev 2000; 4: CD001331.
28. Bracken M, Shepard MJ, Holford T, Leo-Summers L, Aldrich EF, Fazl M et al. Administration of methyl-prednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the third national acute spinal cord injury randomized controlled trial. JAMA 1997; 277: 1597-604.
29. Kalita J, Misra UK. Is methyl prednisolone useful in acute transverse myelitis? Spinal Cord 2001; 39: 471-76.